FeesSafety
Pluang+

CVS expands fall product range with new collectibles, toys, beauty, and seasonal snacks

Market News
23 Oct 2026
PRNewsWire
View Source
Bullish
CVS expands fall product range with new collectibles, toys, beauty, and seasonal snacks

CVS Pharmacy has announced an expanded fall assortment featuring new collectibles like Pokémon cards, nostalgic toys, exclusive beauty products, and limited-edition seasonal snacks. This move aims to create moments of discovery for shoppers by regularly introducing fresh and unexpected items in stores and online. The expanded range taps into growing adult interest in collectibles and trending toys, offering unique finds that blend nostalgia with novelty. These products are available at participating CVS stores and on CVS.com while supplies last.

CVS Pharmacy's expanded fall collectibles and seasonal exclusives are noted here with Pluang's Consumer Cyclical sector data as of Oct 23, 2026 18:51 WIB. Of 134 priced US stocks in this sector, 30 rose and 100 fell today. Notable movers include LULU at USD 102.40 with a -1.60% change and a typical hold time on Pluang of 107 days, ONON at USD 33.47 down -1.57%, and CZR at USD 28.62 down -1.55%.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
17 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App